Cefprozil and Januvia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefprozil (cefprozil) and Januvia (sitagliptin phosphate). Common drug interactions include actinic keratosis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cefprozil and Januvia. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.



On Aug, 07, 2026

16 people who take Cefprozil and Januvia together, and have interactions are studied.

Cefprozil and Januvia drug interactions.

What are the common drug interactions of Cefprozil and Januvia, by gender? *:

female:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Chronic kidney disease
  4. Eczema nummular (circular or oval patches of eczema with well-defined edges)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Labile blood pressure (wildly fluctuating blood pressure)
  7. Neoplasm skin (skin tumour)
  8. Rash erythematous (redness of the skin)
  9. Rash pruritic (redness with itching)
  10. Renal failure (kidney dysfunction)

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Diarrhoea
  4. Dizziness
  5. Dyspepsia (indigestion)
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Head injury
  10. Hip disarticulation

What are the common drug interactions of Cefprozil and Januvia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  4. Infection
  5. Multiple allergies (allergy to multiple agents)
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Nasal polyps (masses that develop in the lining of the nose)

50-59:

  1. Vision blurred
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  8. Asthenia (weakness)
  9. Blood triglycerides increased
  10. Chest discomfort

60+:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Skin cancer
  4. Skin graft failure (skin transplant failed)
  5. Skin haemorrhage (bleeding into skin)
  6. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  7. Wound
  8. Chronic kidney disease
  9. Blood glucose increased
  10. Hyperhidrosis (abnormally increased sweating)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 50.00%
  2. Pain: 6 people, 37.50%
  3. Blood Pressure Abnormal: 5 people, 31.25%
  4. High Blood Cholesterol: 5 people, 31.25%
  5. High Blood Pressure: 5 people, 31.25%
  6. Asthma: 4 people, 25.00%
  7. Infection: 4 people, 25.00%
  8. Stress And Anxiety: 3 people, 18.75%
  9. Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 18.75%
  10. Cardiac Failure: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and Januvia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefprozil and Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefprozil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Januvia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefprozil and sitagliptin phosphate (the active ingredients of Cefprozil and Januvia, respectively), and Cefprozil and Januvia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: